StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2026 it was -$2.30M.

Annual ebitda

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$2.30M–
FY2025Mar 31, 2025-$2.21M–
FY2024Mar 31, 2024-$1.89M–
FY2023Mar 31, 2023-$1.72M–

More Cellyan Biotechnology figures

See a number that looks wrong?